A Pharmacokinetic Study of a Novel Nutritional Product on Healthy Men and Women
Condition(s):Healthy AgingLast Updated:March 18, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Healthy AgingLast Updated:March 18, 2024Not yet recruiting
Condition(s):Tobacco-Related CarcinomaLast Updated:March 18, 2024Not yet recruiting
Condition(s):Hematopoietic and Lymphoid System Neoplasm; Malignant Solid NeoplasmLast Updated:March 18, 2024Recruiting
Condition(s):RosaceaLast Updated:March 15, 2024Recruiting
Condition(s):Hematopoietic and Lymphoid System Neoplasm; Lymphedema; Malignant Solid NeoplasmLast Updated:March 12, 2024Not yet recruiting
Condition(s):Obesity, Morbid; Labor PainLast Updated:March 12, 2024Enrolling by invitation
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:March 12, 2024Recruiting
Condition(s):Acute Pain; Pediatric ALL; Procedural Pain; BurnsLast Updated:March 12, 2024Enrolling by invitation
Condition(s):Ovarian Cancer; Non-small Cell Lung CancerLast Updated:March 12, 2024Not yet recruiting
Condition(s):Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Nodal Marginal Zone Lymphoma; Recurrent Splenic Marginal Zone Lymphoma; Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Nodal Marginal Zone Lymphoma; Refractory Splenic Marginal Zone LymphomaLast Updated:March 8, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.